Elsevier

Gender Medicine

Volume 6, Issue 3, September 2009, Pages 419-432
Gender Medicine

Women with atrial fibrillation: Greater risk, less attention

https://doi.org/10.1016/j.genm.2009.09.008Get rights and content

Abstract

Background: In 1995, atrial fibrillation (AF) was estimated to affect 2.2 million people in the United States. After the age of 75 years (the median age for onset of AF), ~60% of people with AF are women. Women have a significantly higher risk of AF-related stroke than do men and are more likely to live with stroke-related disability and a significantly lower quality of life.

Objective: This article provides an overview of the contributing factors and clinical presentation of AF in women and offers a rational, safe, effective, and gender-specific approach to therapy for women with AF.

Methods: Search engines, including PubMed and Google Scholar, were used to review the English-language literature addressing AF gender differences for the years 1989–2009. The search term atrial fibrillation was combined with multiple other terms, as well as with female, gender, sex, or women. Full-length manuscripts were reviewed. Original studies obtained were searched for additional relevant manuscripts using the cited references.

Results: Studies have shown that women are more likely than men to experience symptomatic attacks, a higher frequency of recurrences, and significantly higher heart rates during AF. Hormonal fluctuations during the menstrual cycle that affect QT intervals are an important consideration when selecting antiarrhythmic drugs for premenopausal women. Women are treated with statins less frequently than are men, possibly contributing to an increased incidence of AF in women. Women may have a higher incidence of AF because of the association with obesity. Some evidence suggests that women have a significantly higher risk of bleeding from anticoagulation. Reluctance among physicians and patients to use warfarin may be especially problematic in elderly women, who benefit most from it. Outcomes after catheter ablation for AF are similar between the sexes, yet women are referred later and less frequently.

Conclusions: We favor emphasizing therapies to prevent AF and ensure safe arrhythmia management (ie, rate control and appropriate anticoagulation) once AF has been diagnosed. Gender differences should be kept in mind for women with AF to reduce risks and improve quality of life.

References (82)

  • AB Curtis et al.

    Clinical factors that influence response to treatment strategies in atrial fibrillation: The Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) study

    Am Heart J.

    (2005)
  • MH Lehmann et al.

    Sex difference in risk of torsades de pointes with d,l-sotalol

    Circulation.

    (1996)
  • N Jochmann et al.

    Female-specific aspects in the pharmacotherapy of chronic cardiovascular diseases

    Eur Heart J.

    (2005)
  • C Torp-Pedersen et al.

    Dofetilide in patients with congestive heart failure and left ventricular dysfunction

    N Engl J Med.

    (1999)
  • M Nakagawa et al.

    Influence of menstrual cycle on QT interval dynamics

    Pacing Clin Electrophysiol.

    (2006)
  • AS Go et al.

    Prevalence of diagnosed atrial fibrillation in adults: National implications for rhythm management and stroke prevention: The AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study

    JAMA.

    (2001)
  • G Patti et al.

    Randomized trial of atorvastatin for reduction of postoperative atrial fibrillation in patients undergoing cardiac surgery: Results of the ARMYDA-3 (Atorvastatin for Reduction of MYocardial Dysrhythmia After cardiac surgery) study

    Circulation.

    (2006)
  • A Tveit et al.

    Analysis of pravastatin to prevent recurrence of atrial fibril-lation after electrical cardioversion

    Am J Cardiol.

    (2004)
  • D Roy et al.

    Rhythm control versus rate control for atrial fibrillation and heart failure

    N Engl J Med.

    (2008)
  • Heart disease and stroke statistics-2008 update: A report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee

  • MC Fang et al.

    Gender differences in the risk of ischemic stroke and peripheral embolism in atrial fibrillation: The AnTicoagulation and Risk factors In Atrial fibrillation (ATRIA) study

    Circulation.

    (2005)
  • RH Falk

    Atrial fibrillation [published correction appears in N Engl J Med. 2001;344:1876]

    N Engl J Med.

    (2001)
  • EJ Benjamin et al.

    Impact of atrial fibrillation on the risk of death: The Framingham Heart Study

    Circulation.

    (1998)
  • S Paeratakul et al.

    The relation of gender, race and socioeconomic status to obesity and obesity comorbidities in a sample of US adults

    Int J Obes Relat Metab Disord.

    (2002)
  • K Umetani et al.

    High prevalence of paroxysmal atrial fibrillation and/or atrial flutter in metabolic syndrome

    Circ J.

    (2007)
  • TJ Wang et al.

    Obesity and the risk of new-onset atrial fibrillation

    JAMA.

    (2004)
  • A Zacharias et al.

    Obesity and risk of new-onset atrial fibrillation after cardiac surgery

    Circulation.

    (2005)
  • RJ Aviles et al.

    Inflammation as a risk factor for atrial fibrillation

    Circulation.

    (2003)
  • N Sata et al.

    C-reactive protein and atrial fibrillation. Is inflammation a consequence or a cause of atrial fibrillation?

    Jpn Heart J.

    (2004)
  • J Dernellis et al.

    Relationship between C-reactive protein concentrations during gluco-corticoid therapy and recurrent atrial fibrillation

    Eur Heart J.

    (2004)
  • J Halonen et al.

    Cortico-steroids for the prevention of atrial fibrillation after cardiac surgery: A randomized controlled trial

    JAMA.

    (2007)
  • WL Hobbs et al.

    Anorexia nervosa: An overview

    Am Fam Physician.

    (1996)
    WL Hobbs et al.

    Anorexia nervosa: An overview

    Am Fam Physician.

    (1996)
  • M Kollai et al.

    Cardiac vagal hyperactivity in adolescent anorexia nervosa

    Eur Heart J.

    (1994)
  • R Mizuno et al.

    Anorexia nervosa with left atrial failure

    Intern Med.

    (1998)
  • A Gupta et al.

    Current concepts in the mechanisms and management of drug-induced QT prolongation and torsade de pointes

    Am Heart J.

    (2007)
  • KJ Mukamal et al.

    Alcohol consumption and risk of atrial fibrillation in men and women: The Copenhagen City Heart Study

    Circulation.

    (2005)
  • D Conen et al.

    Alcohol consumption and risk of incident atrial fibrillation in women

    JAMA.

    (2008)
  • EJ Benjamin et al.

    Independent risk factors for atrial fibrillation in a population-based cohort. The Framingham Heart Study

    JAMA.

    (1994)
  • ED Eaker et al.

    Anger and hostility predict the development of atrial fibrillation in men in the Framingham Offspring Study

    Circulation.

    (2004)
  • ED Eaker et al.

    Tension and anxiety and the prediction of the 10-year incidence of coronary heart disease, atrial fibrillation, and total mortality: The Framingham Offspring Study

    Psychosom Med.

    (2005)
  • KH Humphries et al.

    Newonset atrial fibrillation: Sex differences in presentation, treatment, and outcome

    Circulation.

    (2001)
  • Cited by (68)

    • Sex and stroke risk factors: A review of differences and impact

      2024, Journal of Stroke and Cerebrovascular Diseases
    • Sex Differences in Periprocedural and Long-Term Outcomes Following Transcatheter Left Atrial Appendage Occlusion: A Systematic Review and Meta-Analysis

      2023, Cardiovascular Revascularization Medicine
      Citation Excerpt :

      Outcomes may also be influenced by the device used, with higher periprocedural complications noted with use of Amplatzer™ Amulet™ as compared to the newer Watchman™ FLX LAAO device. [39] A higher proportion of women undergoing LAAO in real-world practice as compared to clinical trials perhaps played a role in unearthing sex bias in the latter, compounded by factors such as a tendency towards conservative measures causing delays in referral, higher inherent bleeding risk in females, and prevalent differences in the natural course of AF management in women [18,40]. On follow-up, we found similar rates of ischemic stroke (2 to 4 %) and CV mortality (5 to 12 %) as previously reported [8,41–44].

    • The Canadian Women's Heart Health Alliance Atlas on the Epidemiology, Diagnosis, and Management of Cardiovascular Disease in Women — Chapter 5: Sex- and Gender-Unique Manifestations of Cardiovascular Disease

      2022, CJC Open
      Citation Excerpt :

      Women with AF suffer larger strokes and have greater admission rates to long-term care.141-143 AF is typically associated with obesity and VHD in women, and with CAD in men.142-144 Women tend to be more symptomatic with AF and have higher recurrence rates,141,143 and women with paroxysmal AF tend to have faster and longer heart rate responses compared with men.145

    View all citing articles on Scopus
    *

    Current affiliation: Illinois Masonic Medical Center, Chicago, Illinois.

    View full text